Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

IMP3 can predict aggressive behaviour of lung adenocarcinoma.

Beljan Perak R, Durdov MG, Capkun V, Ivcevic V, Pavlovic A, Soljic V, Peric M.

Diagn Pathol. 2012 Nov 28;7:165. doi: 10.1186/1746-1596-7-165.

2.

Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid.

Liu L, Cohen C, Siddiqui MT.

Acta Cytol. 2012;56(4):425-30. doi: 10.1159/000337439. Epub 2012 Jul 25.

PMID:
22846220
3.
4.

The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.

Stoll LM, Johnson MW, Gabrielson E, Askin F, Clark DP, Li QK.

Cancer Cytopathol. 2010 Dec 25;118(6):441-9. doi: 10.1002/cncy.20108. Epub 2010 Sep 9.

5.

Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.

Tan D, Li Q, Deeb G, Ramnath N, Slocum HK, Brooks J, Cheney R, Wiseman S, Anderson T, Loewen G.

Hum Pathol. 2003 Jun;34(6):597-604.

PMID:
12827614
6.

IMP3 Predicts Invasion and Prognosis in Human Lung Adenocarcinoma.

Yan J, Wei Q, Jian W, Qiu B, Wen J, Liu J, Fu B, Zhou X, Zhao T.

Lung. 2016 Feb;194(1):137-46. doi: 10.1007/s00408-015-9829-0. Epub 2015 Nov 25.

PMID:
26608347
7.

IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study.

Wang L, Li HG, Xia ZS, Lü J, Peng TS.

Chin Med J (Engl). 2010 Dec;123(24):3554-8.

PMID:
22166630
8.

[Clinicopathological and prognostic significance of a panel of tumor biomarkers in lung adenocarcinoma: a tissue microarray study].

Yang X, Xue L, Guo L, Wen P, Lin D.

Zhongguo Fei Ai Za Zhi. 2014 Mar;17(3):243-53. doi: 10.3779/j.issn.1009-3419.2014.03.11. Chinese.

9.

Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.

Dejmek A, Naucler P, Smedjeback A, Kato H, Maeda M, Yashima K, Maeda J, Hirano T.

Diagn Cytopathol. 2007 Aug;35(8):493-7.

PMID:
17636482
10.

IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.

Walter O, Prasad M, Lu S, Quinlan RM, Edmiston KL, Khan A.

Hum Pathol. 2009 Nov;40(11):1528-33. doi: 10.1016/j.humpath.2009.05.005. Epub 2009 Aug 19.

PMID:
19695680
11.

Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma--sensitivity of TTF-1 is superior to napsin.

Terra SB, Aubry MC, Yi ES, Boland JM.

Hum Pathol. 2014 Feb;45(2):294-302. doi: 10.1016/j.humpath.2013.09.005. Epub 2013 Dec 12.

PMID:
24331839
12.

Lepidic and micropapillary growth pattern and expression of Napsin A can stratify patients of stage I lung adenocarcinoma into different prognostic subgroup.

Yang X, Liu Y, Lian F, Guo L, Wen P, Liu XY, Lin DM.

Int J Clin Exp Pathol. 2014 Mar 15;7(4):1459-68. eCollection 2014.

13.

Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data.

Sakurai H, Asamura H, Miyaoka E, Yoshino I, Fujii Y, Nakanishi Y, Eguchi K, Mori M, Sawabata N, Okumura M, Yokoi K; Japanese Joint Committee of Lung Cancer Registry..

Eur J Cardiothorac Surg. 2014 Jan;45(1):100-7. doi: 10.1093/ejcts/ezt284. Epub 2013 May 31.

PMID:
23729748
14.

Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung.

Lee JG, Kim S, Shim HS.

Lung Cancer. 2012 Jul;77(1):156-61. doi: 10.1016/j.lungcan.2012.02.013. Epub 2012 Mar 13.

PMID:
22418245
15.

TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks.

Fatima N, Cohen C, Lawson D, Siddiqui MT.

Cancer Cytopathol. 2011 Apr 25;119(2):127-33. doi: 10.1002/cncy.20135. Epub 2011 Feb 1.

16.

Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.

Aikawa E, Kawahara A, Hattori S, Yamaguchi T, Abe H, Taira T, Azuma K, Kage M.

Cancer Cytopathol. 2011 Oct 25;119(5):335-45. doi: 10.1002/cncy.20162. Epub 2011 Jun 29.

17.

Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.

Yuan RH, Wang CC, Chou CC, Chang KJ, Lee PH, Jeng YM.

Ann Surg Oncol. 2009 Jun;16(6):1711-9. doi: 10.1245/s10434-009-0446-0. Epub 2009 Apr 9.

PMID:
19357927
18.

Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas.

Zhan P, Shen XK, Qian Q, Wang Q, Zhu JP, Zhang Y, Xie HY, Xu CH, Hao KK, Hu W, Xia N, Lu GJ, Yu LK.

Oncol Rep. 2012 Apr;27(4):1072-8. doi: 10.3892/or.2011.1605. Epub 2011 Dec 21.

19.

Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer.

Misch D, Blum T, Boch C, Weiss T, Crolow C, Griff S, Mairinger T, Bauer TT, Kollmeier J.

Diagn Pathol. 2015 Apr 2;10:21. doi: 10.1186/s13000-015-0250-z.

20.

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.

Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL.

Mod Pathol. 2011 Oct;24(10):1348-59. doi: 10.1038/modpathol.2011.92. Epub 2011 May 27.

Supplemental Content

Support Center